The largest database of trusted experimental protocols

14 protocols using inertsil ods 4 column

1

Isolation and Characterization of Pigments from Passiflora coerulea

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh petals of each species were extracted using 5% HCOOH in MeOH. After removing solvents by evaporation, each extract was applied to column chromatography using Diaion HP-20SS (Mitsubishi Chemical Co., Japan) and eluted with 0.5% TFA (trifluoroacetic acid), 10% MeCN containing 0.5% TFA and 25% MeCN containing 0.5% TFA. The fractions were chromatographed on a Sephadex LH-20 gel, eluenting with MeOH/H 2 O/HCOOH (70:25:5). The mixtures were applied to preparative HPLC using a Shimadzu HPLC system equipped with an Inertsil ODS-4 column (I.D. 10 × 250 mm, GL Sciences Inc., Japan) under the following conditions. The eluent was 10% MeCN containing 5% HCOOH to 20% MeCN containing 5% HCOOH at a flow rate of 3 -3.5 mL min -1 .
Three anthocyanins (1-3), four flavonols (4-7), and three flavones (8-10) were isolated from P. coerulea var. The MS was performed on a Shimadzu LC/MS system using an Inertsil ODS-4 column (I.D. 10×250 mm, GL Sciences Inc., Tokyo) equipped with a PDA detector (4.5 kV for ESI + and 3.5 kV for ESI -; interface temperature as 250°C).
NMR spectroscopy was recorded on a Bruker AVANCE III HD 800 spectrometer equipped with a 5-mm TCI cryogenic probe and Z-axis gradient (Bruker Biospin AG, Switzerland). All spectra were obtained in 0.
+ Open protocol
+ Expand
2

Lignin Precursor Transport Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A transport assay was conducted as reported previously16 (link),22 (link). Uptake of lignin precursors by membrane vesicles was measured at 28 °C for 20 min in 100 μL reaction mixture [50 mM HEPES-KOH (pH 7.5), 5 mM Mg/ATP, 50 μM lignin precursors and membrane vesicles (~15 μg protein)], unless otherwise stated. Eighty microliters of the reaction mixture were filtered using a Sephadex G-50 spin column and centrifuged at 2,000 rpm for 2 min. An equal volume of methanol was added to the filtrate for HPLC analysis. Ten microliters of each sample were injected onto a reversed-phase Inertsil® ODS-4 column (150 × 4.6 mm i.d., 5 µm; GL Sciences, Tokyo, Japan) maintained at 30 °C. The flow rate was 1.0 mL min−1 throughout the entire analysis with 0.1% (v/v) acetic acid and 15%, 25%, or 30% (v/v) methanol for determination of p-glucocoumaryl alcohol, p-coumaryl alcohol, or p-coumaric acid, respectively. The peaks of lignin precursors were detected by measuring the absorbance at 260 nm. Ammonium chloride and vanadate were dissolved in water, whereas bafilomycin A1 and gramicidin D were dissolved in DMSO, and nigericin was dissolved in methanol. In the control, DMSO or methanol was added to the reaction mixture to a final concentration of 1%. Data are given as technical replicates.
+ Open protocol
+ Expand
3

Quantification of d8-TCA and Methotrexate

Check if the same lab product or an alternative is used in the 5 most similar protocols
The d8-TCA concentration was analysed by LC-MS/MS (LCMS-8030; Shimadzu, Kyoto, Japan) according to a previously described method52 (link). The methotrexate concentration was determined in electrospray ionization (ESI) mode with an Inertsil ODS-4 column (100 mm × 2.10 mm, 3 μm, GL Sciences Inc., Tokyo, Japan). The selected reaction monitoring transitions were 454.6.1 m/z > 308.4 m/z for methotrexate and 180.0 m/z > 110.10 m/z for the internal standard (phenacetin). The column temperature was maintained at 40 °C. The mobile phase consisted of acetonitrile (organic phase) and ultrapure water with 0.1% formic acid (aqueous phase). The substrate amounts were normalized to the protein amounts using a bicinchoninic acid (BCA) protein assay kit (Pierce, Rockford, IL).
To simultaneously quantify 15 BA constituents, a Shimadzu LC-20AD HPLC system coupled with an AB Sciex API 4000 triple quadrupole mass spectrometer was used as previously described53 (link). The total BA concentration was determined using a total BA reagent kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China).
+ Open protocol
+ Expand
4

Solubility Screening for SMEDDS Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To select appropriate components for the development of the SMEDDS formulation, solubility studies were conducted for various oils and surfactants.18 (link) Excess amounts of MTX (approximately 50 mg) was transferred to 15 mL conical tube (SPL #50,015) containing 3 mL of pure oils or 10% (w/v) aqueous surfactant solutions. Then, the mixture was vortexed and kept for 7 days at 25 °C in a shaking water-bath to facilitate the solubilization. Subsequently, 1 mL of samples were centrifuged at 10,000 g for 10 min (Hanil Science Industrial Co., South Korea) to separate the undissolved MTX. The supernatant was taken and diluted with mobile phase for high performance liquid chromatography (HPLC) analysis for the quantification of MTX. The concentration of MTX in the sample was quantified by the HPLC system (Agilent 1260 Infinity, Agilent Technologies, USA) consisting of the Chem Station software, G1311C 1260 Quat Pump, and G1314B 1260 VWD VL detector. The Inertsil ODS-4 column (GL Sciences, Japan, 4.6 mmI.D. x 250 mm, 5 μm) was used, and the column temperature was maintained at 25 °C. The mobile phase consisted of 0.1 M dibasic phosphate (pH was adjusted to 3.0 with hydrochloride solution) and methanol at the volume ratio of 74/26, respectively. The mobile phase was eluted at a flow rate of 1 mL/min. The eluent was monitored by the detector at 303 nm.
+ Open protocol
+ Expand
5

HPLC Purification for Organic Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
An analytical GL Science Inertsil ODS-4 column (100 Å, 5 μm, 4.6 mm × 250 mm) was used to monitor reactions and for final purity analysis. The signals were monitored by a UV detector (260 nm) or fluorescent detector (Ex 260 nm, Em 310 nm). Analysis was performed under a gradient running condition (solvent A: H2O with 0.1% TFA; solvent B: acetonitrile with 0.1% TFA; flow rate: 1 mL/min; B%: 20–40 within 25 min). With similar running conditions, the analytical Inertsil ODS-4 column was used for separating up to 3 mg of products, and a semipreparative Inertsil ODS-4 column (100 Å, 5 μm, 10 mm × 250 mm) was used for larger scales with a flow rate of 4 mL/min.
+ Open protocol
+ Expand
6

GABA Extraction and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The methods described in Jin et al. (2019 (link)) and Li, Liu, Peng, et al. (2020 ) were followed for the extraction and determination of GABA with some modifications. Briefly, 0.1 g of fresh sample was homogenized with 1 mL of 50% ethanol solution (containing 0.1 M HCl), then centrifuged for 15 min at 13,500 × g, filtered through a 0.22‐μm filter, and finally diluted 10 fold with methanol (Sigma‐Aldrich) for detection by LC–MS (LC: AC, ExionLC; MS: Q‐trap5500, AB Sciex Pret. Ltd). Separation used an Inertsil ODS‐4 column (3 μm particle size, 3 × 150 mm; GL Sciences Inc.). The mobile phases A and B were 0.1% methanoic acid and acetonitrile, respectively. The GABA standard (A2192) was purchased from Sigma‐Aldrich. The GABA retention time was 1.29 min.
+ Open protocol
+ Expand
7

Phenacetin O-dealkylation Assay for CYP1A2

Check if the same lab product or an alternative is used in the 5 most similar protocols
The method of Butler et al. was followed to determine the hepatic phenacetin O-dealkylation activity selective for CYP1A2 [39 (link)]. The incubation mixture contained a NADPH-generating system (1 mM NADP, 10 mM glucose 6-phosphate, 5 mM MgCl2 and 2 units/mL glucose 6-phosphate dehydrogenase), human liver microsomes (1 mg/mL) and phenacetin (200 μM). After a 20-min incubation period, the reaction was terminated by ice-cold methanol, and the incubation mixture was centrifuged for 10 min at 10,000× g. The metabolite (acetaminophen) formation was determined by a high-performance liquid chromatographic analysis, using Inertsil ODS-4 column (75 × 2.1 mm, 3 μm; GL Sciences Inc., Tokyo, Japan) and a mobile phase containing 30% acetonitrile and 0.1% formic acid [39 (link)]. A CYP1A2 enzyme assay for each donor was performed in triplicate, and the activity was expressed as pmol acetaminophen/(mg protein ∗ min).
+ Open protocol
+ Expand
8

Olanzapine Plasma Concentration Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols
The blood samples were taken directly before the morning dose of olanzapine, 12 h after the evening dose. The blood samples were taken at the same time for CYPtesting and for therapeutic drug monitoring. Olanzapine plasma concentration was determined by LC–MS/MS using an Inertsil ODS-4 column (75 × 2.1 mm, 3 µm; GL Sciences Inc., Tokyo, Japan) and mobile phases of 0.1% formic acid and acetonitrile in gradient running mode. The samples were analyzed using positive electrospray ionization (Sciex API 2000, MDS AB Sciex, Toronto, Canada) and multiple reaction monitoring mode for quantitation of olanzapine (m/z 313.3/256.1 and 313.3/198.1). Plasma concentrations divided by the corresponding 24-h olanzapine dose on a mg/kg basis were calculated for normalized olanzapine plasma concentrations.
+ Open protocol
+ Expand
9

HPLC Analysis of Bioactive Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The experiment was performed on a Thermo Ultimate 3000 HPLC system coupled with an Ultimate 3000 diode array detector (Thermo Fisher Scientific, USA). The chromatographic separation was performed on an Inertsil ODS-4 column (4.6 mm × 250 mm × 5 μm; GL-science Inc., Tokyo, Japan), using ultrapure water–0.1% formic acid solution (eluent A) and methanol (eluent B) as mobile phases at a flow rate of 0.8 mL min−1. The column temperature was maintained at 30 °C. Two mobile phases were programmed as follows: 0–5 min, 5–22% B; 5–20 min, 22% B; 20–35 min, 22–24% B; 35–45 min, 24–25% B; 45–50 min, 25–40% B; 50–60 min, 40–45% B. The injection volume was 10 μL. Chromeleon Chromatography Data System software 7.0 was used for instrument control, data acquisition, and data analysis. The chromatographic peaks of these nine compounds (GA, C, EC, EGC, ECG, EGCG, theobromine, theophylline, and caffeine) were confirmed by comparing their retention time and UV-Vis absorbance spectra with those of the authentic standards. Quantification of these compounds was conducted by the integration of the peak using the external standard method. Calibration curves of these nine compounds were obtained at a detection wavelength of 280 nm over different concentrations, of which the calibration curves were shown in Fig. S1 (ESI).
+ Open protocol
+ Expand
10

Flow-controlled CSTR Separation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cetoni Nemesys syringe pumps with Hamilton syringes were used to control input and the flow profile was programmed using the Cetoni neMESYS software26 (link),41 (link). Before performing the designed flow profile, the whole system was equilibrium with buffer for two hours. The outflow of the CSTR was collected using a fraction collector, collecting for either 30 or 15 minutes or three droplets per fraction. The ion-pair HPLC analysis was adapted from ref. 26 (link) and performed on Shimadzu Nexera X3 HPLC system with an Inertsil ODS-4 column (3 μm, 150 × 4.6 mm; GL Science) and a guard column (3 μm; 10 × 4.6 mm) at 40 °C. The elution gradient was as follows: 100% buffer A (100 mM potassium phosphate buffer (pH 6.4) with 8 mM ion-pair reagent tetrabutylammonium bisulfate, filtered before use) for 13 min; 0–77% linear gradient of buffer B for 22 min; 77–100% buffer B (70% buffer A with 30% acetonitrile) for 1 min; and 100% buffer B for 14 min. The flow rate was maintained at 1 ml/min. Peaks were identified by comparison with standard samples. The concentration was obtained from the integrated peak areas with the calibration curve of each standard.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!